The dioxin/aryl hydrocarbon receptor mediates downregulation of osteopontin gene expression in a mouse model of gastric tumourigenesis

Oncogene

Volumn 24, Issue 19, 2005, Pages 3216-3222

  Kuznetsov, Nikolai V ^a   Andersson, Patrik ^b   Gradin, Katarina ^b   Von Stein, Petra ^a   Dieckmann, Andreas ^a   Pettersson, Sven ^b   Hanberg, Annika ^b   Poellinger, Lorenz ^b  

^a InDex Pharmaceuticals AB   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dioxin aryl hydrocarbon receptor; Gastric cancer; Gene expression profiling; Osteopontin; Suppression subtractive hybridization

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; COMPLEMENTARY DNA; CYTOCHROME P450 1A1; DIOXIN; DRUG METABOLIZING ENZYME; MESSENGER RNA; OSTEOPONTIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MATRIX; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA PROBE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TRANSCRIPTION REGULATION; TUMOR LOCALIZATION;

ANIMALS; BONE AND BONES; DOWN-REGULATION; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; HYDROCARBONS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MODELS, GENETIC; MUTATION; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SIALOGLYCOPROTEINS; STOMACH NEOPLASMS; TIME FACTORS; TISSUE DISTRIBUTION;

MUS MUSCULUS;

EID: 18844399363     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208529     Document Type: Article

References (53)

1. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D and Yeatman TJ. (2002). J. Natl. Cancer Inst., 94, 513-521.
2. Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S, Hanberg A and Poellinger L. (2002). Proc. Natl. Acad. Sci. USA, 99, 9990-9995.
3. Andersson P, Ridderstad A, McGuire J, Pettersson S, Poellinger L and Hanberg A. (2003). Biochem. Biophys. Res. Commun., 302, 336-341.
4. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ and Cantor H. (2000). Science, 287, 860-864.
5. Baumgarth N, Herman OC, Jager GC, Brown L and Herzenberg LA. (1999). Proc. Natl. Acad. Sci. USA, 96, 2250-2255.
6. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA and Chen J. (2000). J. Exp. Med., 192, 271-280.
7. Bidder M, Shao JS, Charlton-Kachigian N, Loewy AP, Semenkovich CF and Towler DA. (2002). J. Biol. Chem., 277, 44485-44496.
8. Boes M, Prodeus AP, Schmidt T, Carroll MC and Chen J. (1998). J. Exp. Med., 188, 2381-2386.
9. Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF and Senger DR. (1992). Mol. Biol. Cell, 3, 1169-1180.
10. Brown LF, Papadopoulos-Sergiou A, Berse B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF and Senger DR. (1994). Am. J. Pathol., 145, 610-623.
11. Church GM and Gilbert W. (1984). Proc. Natl. Acad. Sci. USA, 81, 1991-1995.
12. Craig AM and Denhardt DT. (1991). Gene, 100, 163-171.
13. Crawford HC, Matrisian LM and Liaw L. (1998). Cancer Res., 58, 5206-5215.
14. Denhardt DT, Giachelli CM and Rittling SR. (2001a). Annu. Rev. Pharmacol. Toxicol., 41, 723-749.
15. Denhardt DT, Mistretta D, Chambers AF, Krishna S, Porter JF, Raghuram S and Rittling SR. (2003). Clin. Exp. Metastasis, 20, 77-84.
16. Denhardt DT and Noda M. (1998). J. Cell. Biochem. Suppl., 30-31, 92-102.
17. Denhardt DT, Noda M, O'Regan AW, Pavlin D and Berman JS. (2001b). J. Clin. Invest., 107, 1055-1061.
18. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM and Gonzalez FJ. (1995). Science, 268, 722-726.
19. Fernandez-Salguero PM, Ward JM, Sundberg JP and Gonzalez FJ. (1997). Vet. Pathol., 34, 605-614.
20. Frueh FW, Hayashibara KC, Brown PO and Whitlock Jr JP. (2001). Toxicol. Lett., 122, 189-203.
21. Furger KA, Menon RK, Tuckl AB, Bramwelll VH and Chambers AF. (2001). Curr. Mol. Med., 1, 621-632.
22. Gillesby BE, Stanostefano M, Porter W, Safe S, Wu ZF and Zacharewski TR. (1997). Biochemistry, 36, 6080-6089.
23. Gu YZ, Hogenesch JB and Bradfield CA. (2000). Annu. Rev. Pharmacol. Toxicol., 40, 519-561.
24. Iizuka J, Katagiri Y, Tada N, Murakami M, Ikeda T, Sato M, Hirokawa K, Okada S, Hatano M, Tokuhisa T and Uede T. (1998). Lab. Invest., 78, 1523-1533.
25. Kleman MI, Poellinger L and Gustafsson J. (1994). J. Biol. Chem., 269, 5137-5144.
26. Kolluri SK, Balduf C, Hofmann M and Göttlicher M. (2001). Cancer Res., 61, 8534-8539.
27. Kolluri SK, Weiss C, Koff A and Göttlicher M. (1999). Genes Dev., 13, 1742-1753.
28. Kurachi M, Hashimoto S, Obata A, Nagai S, Nagahata T, Inadera H, Sone H, Tohyama C, Kaneko S, Kobayashi K and Matsushima K. (2002). Biochem. Biophys. Res. Commun., 292, 368-377.
29. Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, Bentz M, Southard J and Bradfield CA. (2000). Proc. Natl. Acad. Sci. USA, 97, 10442-10447.
30. McGuire J, Okamoto K, Whitelaw ML, Tanaka H and Poellinger L. (2001). J. Biol. Chem., 276, 41841-41849.
31. Mimura J, Ema M, Sogawa K and Fujii-Kuriyama Y. (1999). Genes Dev., 13, 20-25.
32. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, Ema M, Sogawa K, Yasuda M, Katsuki M and Fujii-Kuriyama Y. (1997). Genes Cells, 2, 645-654.
33. Miyazaki Y, Setoguchi M, Yoshida S, Higuchi Y, Akizuki S and Yamamoto S. (1990). J. Biol. Chem., 265, 14432-14438.
34. Morimoto I, Sasaki Y, Ishida S, Imai K and Tokino T. (2002). Genes Chromosomes Cancer, 33, 270-278.
35. Nemir M, Bhattacharyya D, Li X, Singh K, Mukherjee AB and Mukherjee BB. (2000). J. Biol. Chem., 275, 969-976.
36. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H and Zinkernagel RM. (1999). Science, 286, 2156-2159.
37. Ohbayashi T, Oikawa K, Iwata R, Kameta A, Evine K, Isobe T, Matsuda Y, Mimura J, Fujii-Kuriyama Y, Kuroda M and Mukai K. (2001). FEBS Lett., 508, 341-344.
38. Oikawa K, Ohbayashi T, Mimura J, Fujii-Kuriyama Y, Teshima S, Rokutan K, Mukai K and Kuroda M. (2002). Biochem. Biophys. Res. Commun., 290, 984-987.
39. Paciorkowski N, Porte P, Shultz LD and Rajan TV. (2000). J. Exp. Med., 191, 731-736.
40. Pohjanvirta R and Tuomisto J. (1994). Pharmacol. Rev., 46, 483-549.
41. Puga A, Maier A and Medvedovic M. (2000). Biochem. Pharmacol., 60, 1129-1142.
42. Qu H, Brown LF, Dvorak HF and Dvorak AM. (1997). J. Histochem. Cytochem., 45, 21-33.
43. Renault MA, Jalvy S, Belloc I, Pasquet S, Sena S, Olive M, Desgranges C and Gadeau AP. (2003). Circ. Res., 93, 674-681.
44. Rittling SR and Chambers AF. (2004). Br. J. Cancer, 90, 1877-1881.
45. Rivera SP, Saarikoski ST and Hankinson O. (2002). Mol. Pharmacol., 61, 255-259.
46. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular Cloning: A Laboratory Manual 2 edn. Cold Spring Harbour Laboratory Press: Cold Spring Harbour, NY.
47. Schmidt JV, Su GH, Reddy JK, Simon MC and Bradfield CA. (1996). Proc. Natl. Acad. Sci. USA, 93, 6731-6736.
48. Suh J, Jeon YJ, Kim HM, Kang JS, Kaminski NE and Yang KH. (2002). Toxicol. Appl. Pharmacol., 181, 116-123.
49. Svensson C and Lundberg K. (2001). Mol. Pharmacol., 60, 135-142.
50. Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, Pande K, Glover E, Silander T, Craven MW, Reddy JK, Jovanovich SB and Bradfield CA. (2001). Mol. Pharmacol., 60, 1189-1194.
51. Ue T, Yokozaki H, Kitadai Y, Yamamoto S, Yasui W, Ishikawa T and Tahara E. (1998). Int. J. Cancer, 79, 127-132.
52. von Stein OD. (2001). Methods Mol. Biol., 175, 263-278.
53. Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT and Noda M. (2002). Proc. Natl. Acad. Sci. USA, 99, 4556-4561.